233 related articles for article (PubMed ID: 971476)
1. Physiological disposition of verapamil in man.
Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of verapamil in man.
Koike Y; Shimamura K; Shudo I; Saito H
Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):37-47. PubMed ID: 432439
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.
Eichelbaum M; Somogyi A; von Unruh GE; Dengler HJ
Eur J Clin Pharmacol; 1981 Jan; 19(2):133-7. PubMed ID: 7202473
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
5. Disposition kinetics and urinary excretion of verapamil and some of its primary metabolites after oral administration in patients with angina pectoris.
Piotrovskii VK; Rumiantsev DO; Nikolenko SA; Riabokon OS; Metelitsa VI
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):4-11. PubMed ID: 3957489
[TBL] [Abstract][Full Text] [Related]
6. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
Nave R; Bethke TD; van Marle SP; Zech K
Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists. Pharmacokinetic properties.
Kates RE
Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
[TBL] [Abstract][Full Text] [Related]
9. Physiological disposition of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in humans.
Kreis W; Gordon CS; DeJager R; Krakoff IH
Cancer Res; 1975 Sep; 35(9):2453-60. PubMed ID: 1149046
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of verapamil in patients with atrial fibrillation.
Anderson P; BondessoN U; Sylvén C
Eur J Clin Pharmacol; 1982; 23(1):49-57. PubMed ID: 7128672
[TBL] [Abstract][Full Text] [Related]
11. Verapamil disposition kinetics in chronic atrial fibrillation.
Kates RE; Keefe DL; Schwartz J; Harapat S; Kirsten EB; Harrison DC
Clin Pharmacol Ther; 1981 Jul; 30(1):44-51. PubMed ID: 7237897
[TBL] [Abstract][Full Text] [Related]
12. Absorption and first-pass metabolism of 14C-gamma-hydroxybutyric acid.
Lettieri J; Fung HL
Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):425-37. PubMed ID: 935634
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 2nd communication: Absorption and excretion in rabbits, dogs and monkeys after a single administration of 14C-NS-49.
Mukai H; Watanabe S; Morino A
Arzneimittelforschung; 1999 Jun; 49(6):527-32. PubMed ID: 10417870
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of acute intranasal administration of verapamil: comparison with i.v. and oral administration.
Arnold TH; Tackett RL; Vallner JJ
Biopharm Drug Dispos; 1985; 6(4):447-54. PubMed ID: 4084670
[TBL] [Abstract][Full Text] [Related]
16. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
17. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and metabolism of [14C]rosaramicin in dogs.
Lin CC; Kim HK; Marco A; Radwanski E; Symchowicz S
Antimicrob Agents Chemother; 1986 May; 29(5):753-6. PubMed ID: 3729339
[TBL] [Abstract][Full Text] [Related]
20. Absorption, metabolism and excretion after oral administration of a new Ca antagonist, 14C-benidipine hydrochloride to man.
Kobayashi H; Kobayashi S; Dalrymple PD; Wood SG; Chasseaud LF
Xenobiotica; 1997 Jun; 27(6):597-608. PubMed ID: 9211659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
